Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis

Acta Haematologica

Volumn 113, Issue 2, 2005, Pages 124-129

  Kounami, Shinji ^a   Yoshiyama, Megumi ^a   Nakayama, Keiko ^a   Okuda, Masumi ^a   Okuda, Shuji ^a   Aoyagi, Noriyuki ^a   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporin A; Hemophagocytic lymphohistiocytosis; Macrophage activation syndrome; Urine 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DRUG RESPONSE; FEMALE; FEVER; HUMAN; HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; MACROPHAGE ACTIVATION SYNDROME; MALE; MULTIPLE MALFORMATION SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RESPIRATORY FAILURE; SYSTEMIC ONSET JUVENILE CHRONIC ARTHRITIS; THROMBOCYTE COUNT; BLOOD; DRUG EFFECT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; PRESCHOOL CHILD; SYNDROME; URINE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; PLATELET COUNT; RECEPTORS, INTERLEUKIN-2; SYNDROME;

EID: 17144382824     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083450     Document Type: Article

References (18)

1. Hadchouel M, Prieur AM, Griscelli C: Acute hemorrhagic, hepatic, and neurological manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection. J Pediatr 1985;106:561-566.
2. Stéphan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM: Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases. Clin Exp Rheumatol 1993;11:451-456.
3. Sawhney S, Woo P, Murray KJ: Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-426.
4. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM: Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285-1292.
5. Ravelli A: Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-552.
6. Grom AA: Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities? Curr Opin Rheumatol 2003;15:587-590.
7. Wood P: Special meeting on: Nomenclature and classification of arthritis in children; in Munthe E (ed): The Care of Rheumatic Children. Basel, EULAR, 1987, pp 47-50.
8. Imashuku S: Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135-151.
9. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI: Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-444.
10. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A: Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-296.
11. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W: Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 2003;42:375-379.
12. Grom AA: Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004;50:689-698.
13. Komp DM, McNamara J, Buckley P: Elevated soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Blood 1989;73:2128-2132.
14. Hibi S, Ikushima S, Fujiwara F, Hashida T, Tsunamoto K, Todo S, Imashuku S: Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995;75:1700-1705.
15. Imashuku S, Hibi S, Todo S: Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997;130:352-357.
16. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM: Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases. J Pediatr 1996;129:750-754.
17. Janka GE, Schneider EM: Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.
18. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.